Updated 07 August 2026 · HodieLabs Clinical Governance Lead · The HodieLabs Evidence-Based Clinical Library
Ratio of fasting insulin to glucose; another proxy for early insulin resistance. Insulin:Glucose ratio is measured by blood test as part of the Metabolic panel in the HodieLabs Health Blueprint.
A complementary metric to HOMA-IR. Both should be interpreted together. High insulin:glucose ratio with normal glucose confirms compensated insulin resistance.
Associated risks when out of range: Elevated ratio suggests hyperinsulinaemia. The body is producing excess insulin to maintain normal glucose. Early marker of beta-cell compensation before HOMA-IR becomes significantly abnormal.
The HodieLabs Evidence-Based Clinical Library classifies Insulin:Glucose ratio as an strong evidence-tier biomarker. Its reference ranges come from a published authority standard rather than from observational optimisation targets. The standard used here is Metabolic syndrome literature; fasting insulin:glucose ratio <3.0 consistent with optimal glucose homeostasis. Where relevant clinical outcomes are noted on this page, they reflect the guideline literature referenced below.
The HodieLabs Evidence-Based Clinical Library interprets Insulin:Glucose ratio against published clinical authority standards, never arbitrary "optimal" ranges. Measured in ratio:
Recommended testing frequency: Annual, as part of a comprehensive panel. Single markers are always interpreted in context.
Insulin:Glucose ratio is measured in every Health Blueprint at our Melbourne Preventative Health & Longevity Clinic, interpreted by a doctor against the guideline-cited ranges above and tracked over time through your HodieLabs membership.
1. Metabolic syndrome literature; fasting insulin:glucose ratio <3.0 consistent with optimal glucose homeostasis.
This page is general information from the HodieLabs Evidence-Based Clinical Library, not medical advice. Speak with your GP about what testing and care is appropriate for you.
Ratio of fasting insulin to glucose; another proxy for early insulin resistance.
The HodieLabs Evidence-Based Clinical Library optimal range is <3.0 ratio, based on Metabolic syndrome literature; fasting insulin:glucose ratio <3.0 consistent with optimal glucose homeostasis.
Annual testing is recommended for most adults as part of a comprehensive preventative panel; more often if a result is being actively managed.
Evidence-supported levers include: interpret alongside homa-ir and tg/hdl ratio for concordance, dietary carbohydrate reduction and exercise are primary interventions. Interpretation and an action plan should always involve your doctor.
Insulin:Glucose ratio is measured in the HodieLabs Health Blueprint at our Melbourne Preventative Health and Longevity Clinic at 85 Spring Street, with doctor-led interpretation against evidence-based reference ranges.
Insulin:Glucose ratio and 50+ biomarkers, measured and doctor-interpreted at our Melbourne clinic.